RT Journal Article SR Electronic T1 Lung cancer staging: a concise update JF European Respiratory Journal JO Eur Respir J FD European Respiratory Society SP 1800190 DO 10.1183/13993003.00190-2018 A1 Ramón Rami-Porta A1 Sergi Call A1 Christophe Dooms A1 Carme Obiols A1 Marcelo Sánchez A1 William D. Travis A1 Ivan Vollmer YR 2018 UL http://erj.ersjournals.com/content/early/2018/04/05/13993003.00190-2018.abstract AB Diagnosis and clinical staging of lung cancer are fundamental to plan therapy. The techniques for clinical staging – anatomic and metabolic imaging, endoscopies and minimally invasive surgical procedures – should be performed sequentially and with an increasing degree of invasiveness. Intraoperative staging, assessing the magnitude of the primary tumour, the involved structures, and the loco-regional lymphatic spread by means of systematic nodal dissection, is essential to achieve a complete resection. In resected tumours, pathologic staging, with the systematic study of the resected specimens, is the strongest prognosticator and is essential to make further decisions on therapy. In the present decade, the guidelines on lung cancer staging of the American College of Chest Physicians and the European Society of Thoracic Surgeons are based on the best available evidence and are widely followed. Recent advances in the classification of the adenocarcinoma of the lung, with the definition of adenocarcinoma in situ, minimally invasive adenocarcinoma and lepidic predominant adenocarcinoma, and the publication of the 8th edition of the tumour, node and metastasis classification of lung cancer, have to be integrated into the staging process. The present review complements the latest guidelines on lung cancer staging by providing an update of all these issues.Lung cancer staging is a multidisciplinary activity that involves specialists in imaging, endoscopists, surgeons and pathologists at clinical and pathologic stagingFootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Rami-Porta has nothing to disclose.Conflict of interest: Dr. Call has nothing to disclose.Conflict of interest: Dr. Dooms has nothing to disclose.Conflict of interest: Dr. Obiols has nothing to disclose.Conflict of interest: Dr. sánchez has nothing to disclose.Conflict of interest: Dr. Travis has nothing to disclose.Conflict of interest: Dr. Vollmer has nothing to disclose.